Current diagnostic approaches for skin and wound infections are slow, often taking days and requiring invasive procedures with significant lab delays. This waiting period often leads to misguided antibiotic use, prolonged recovery times, and escalating health risks.
Our revolutionary platform combines advanced AI, a proprietary Colorimetric Sensor Array (CSA), and cutting-edge nano-optics in order to identify microbial presence and specific subtypes in real-time. Clinicians will receive definitive answers directly at the point of care, empowering immediate, informed action.
Sensill aims to ensure patients receive the correct antibiotics, right away, leading to significantly faster healing and dramatically reducing the risk of complications, readmissions, or potential complications.
By accelerating crucial decisions in emergency rooms, wound clinics, and post-surgical environments, our solution aims to drive down costs, optimizes resource allocation, and elevates patient outcomes across the entire healthcare system.